Raul Piedrabuena
Cordoba, X, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Progression independent of relapse activity (PIRA) in the Era of high-efficacy treatments.
Journal: Multiple sclerosis and related disorders
Published: June 10, 2025
Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina.
Journal: Clinical neuropharmacology
Published: July 15, 2024
Selection of disease modifying therapies in multiple sclerosis based on patient's age and disease activity: Data from a nationwide registry.
Journal: Journal of the neurological sciences
Published: October 22, 2023
Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
Journal: Multiple sclerosis and related disorders
Published: August 22, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodies.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: September 27, 2022
Evaluation of the use of high-efficacy treatments (HETs) in patients with relapsing-remitting multiple sclerosis in Argentina.
Journal: Multiple sclerosis and related disorders
Published: July 27, 2022
Incidence of COVID-19 after vaccination in people with multiple sclerosis in Argentina: Data from the nationwide registry RelevarEM.
Journal: Multiple sclerosis and related disorders
Published: May 26, 2022
Neuro rehabilitation effectiveness based on virtual reality and tele rehabilitation in people with multiple sclerosis in Argentina: Reavitelem study.
Journal: Multiple sclerosis and related disorders
Published: April 12, 2022
Clinical and demographic characteristics of male MS patients included in the national registry-RelevarEM. Does sex or phenotype make the difference in the association with poor prognosis?
Journal: Multiple sclerosis and related disorders
Published: October 09, 2021
Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: September 07, 2021
COVID-19 in multiple sclerosis and neuromyelitis optica spectrum disorder patients in Latin America: COVID-19 in MS and NMOSD patients in LATAM.
Journal: Multiple sclerosis and related disorders
Published: December 31, 2020
Argentinean consensus guidelines on the identification and clinical care of secondary progressive multiple sclerosis
Journal: Revista de neurologia
Published: December 30, 2020
Last Updated: 09/26/2026